$15.01
-0.70[-4.46%]
Last update: 5:25PM Get Real Time Here
Contineum Therapeutics
(NASDAQ:CTNM)Latest News for Contineum Therapeutics Stock (NASDAQ:CTNM)
Contineum Therapeutics Stock (NASDAQ: CTNM)
Categories: All
Thursday, May 16, 2024
Tuesday, April 30, 2024
- RBC Capital Initiates Coverage On Contineum Therapeutics with Outperform Rating, Announces Price Target of $30Benzinga Newsdesk - Apr 30, 2024, 5:44AM
- Stifel Initiates Coverage On Contineum Therapeutics with Buy Rating, Announces Price Target of $29Benzinga Newsdesk - Apr 30, 2024, 5:20AM
- Morgan Stanley Initiates Coverage On Contineum Therapeutics with Overweight Rating, Announces Price Target of $25Benzinga Newsdesk - Apr 30, 2024, 5:15AM
Tuesday, April 16, 2024
Friday, April 05, 2024
- Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for QuotationBenzinga Newsdesk - Apr 5, 2024, 10:10AM
- Reported Earlier, Contineum Therapeutics Prices Initial Public Offering Of 6,875,000 Class A Common Shares At $16/ShareBenzinga Newsdesk - Apr 5, 2024, 2:17AM